Video

Q&A With Monika Fischer From Indiana University: Tackling New Challenges In Gastroenterology

Author(s):

Patients with irritable bowel disease can have enough issues to deal with in their daily lives. Add a condition like c-diff can make the treatment that much more complicated.

Patients with irritable bowel disease can have enough issues to deal with in their daily lives. Add a condition like c-diff can make the treatment that much more complicated.

Monika Fischer, MD, from Indiana University discussed some of the latest research in this field during the annual meeting of the American College of Gastroenterology in Hawaii.

As fecal microbiota transplant becomes a more common procedure to treat patients with gastrointestinal issues new questions are being answered about factors that can affect its success.

Related Videos
Age, Race, Ethnicity Disparities Hinder Celiac Disease Screening, with Debra Silberg, MD, PhD
Lauren Collen, MD: Advanced Combination Therapy May Be Effective Option for Pediatric Refractory IBD
Lauren Collen, MD: Some Fragrances May be More Prevalent in Exposomes of Children with Crohn’s Disease
Impact of Long Hospital Stays on Pediatric Gastroparesis Management with Christian Sadaka, MD
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
Braden Kuo, MD | Credit: Mass Gen
Satish Rao, MD, PhD | Credit: ACG
Anthony Kerbage, MD | Credit: ResearchGate
© 2024 MJH Life Sciences

All rights reserved.